Yale University Graduate Studies in Chemical Biology

About Chemical Biology at Yale

Faculty

Courses

Admission

Facilities

Contact information

Symposium

 

Chemistry

MCGD

MBB

Pharmacology

 

Chemistry and Chemical Biology: Chemical Diversity,
Natural Product Mode of Action, and Organic Synthesis

A solid grounding in the principles of modern chemistry is essential for any multidisciplinary training at the chemistry-biology interface. Therefore, the first research theme focuses on the fundamentals of organic synthesis, the use of chemical and biological diversity in the design and isolation of novel biological tools and the development of natural products as molecular probes of cell biology. The five laboratories listed below take strong multidisciplinary approaches to each of these three areas.

Craig Crews (MCDB) explores novel mechanisms in cell biology using a combination of chemical and biochemical approaches. This strategy has been referred to as “chemical genetics”, whereby biologically active natural products are used as molecular proves for the exploration of cell biology.

Glenn Micalizio (Chemistry) focuses on the development of new synthetic methods and the application of those methods to the synthetic preparation of biologically active natural products and derivatives. Of particular interest is the design of new reactions and strategies that allow for the simultaneous generation of molecular complexity and structural diversity. The synthetic technology, in combination with a suitable screen, will provide a strategy to enable the evolution of natural product and natural product-like small molecule modulators of protein function. In addition to methods development projects, current natural product interests include ingenol, gambierol, salinosporamide and galiellalactone.

Scott Miller (Chemistry) studies complex molecule synthesis as one of the key disciplines of modern chemical research. The development of new methods for the synthesis and derivatization of such structures is a multi-dimensional activity involving reaction design, development and application. Research in our group focuses on each of these aspects of chemical synthesis. Utilizing the architecture and design principles presented by biologically relevant structures and processes, we seek to discover new reactions and to apply new principles to the selective synthesis of complex molecules.

David Spiegel (Chemistry) develops novel chemical methods to enable the synthesis of a variety of complex molecular targets, including natural products. However, unlike traditional synthetic research programs, these synthetic materials will be used to study the molecular mechanisms that underlie human disease processes (e.g., cancer, Alzheimer's disease, and diabetes) as well as to develop novel therapeutic approaches to these conditions.

Ann Valentine (Chemistry) studies the post-synthetic modification of newly synthesized aromatic polyketide antibiotics by metalloproteins using a variety of bioinorganic, synthetic and biochemical approaches.

 

  Footer